Skip Navigation
Toggle Navigation
Main Nav
Search:
Search Submit
Our Company
About Us
Leadership
Management
Board of Directors
Scientific Advisory Board
Contact Us
Pipeline
Pipeline Overview
Therapeutic Areas
Inflammation
Oncology
Clinical Trials
Compassionate Use
Science
Antibody-Based Therapeutics
Bispecific Platform
Publications
Investors & Media
Investor & Media Home
Press Releases
Events & Presentations
Analyst Coverage
Financials & Filings
SEC Filings
Quarterly Results
Annual Reports & Proxies
Corporate Governance
Documents & Charters
Management
Board of Directors
Scientific Advisory Board
Committee Composition
Investor Resources
Contact Us
Email Alerts
Careers
Contact Us
Search:
Search Toggle
Investors
& Media
Event Details
«
Back
Barzolvolimab Phase 1b Multiple Ascending Dose Chronic Spontaneous Urticaria Study Results AAAAI 2023
Feb 26, 2023 at 5:00 PM EST
Listen to webcast
Supporting Materials
View Poster
426.9 KB
View Presentation
1.6 MB
